227 related articles for article (PubMed ID: 26504856)
41. What is the association of primary sclerosing cholangitis with sex and inflammatory bowel disease in Turkish patients?
Bayraktar Y; Arslan S; Saglam F; Uzunalimoglu B; Kayhan B
Hepatogastroenterology; 1998; 45(24):2064-72. PubMed ID: 9951867
[TBL] [Abstract][Full Text] [Related]
42. ABCB4 mutations in adult patients with cholestatic liver disease: impact and phenotypic expression.
Degiorgio D; Crosignani A; Colombo C; Bordo D; Zuin M; Vassallo E; Syrén ML; Coviello DA; Battezzati PM
J Gastroenterol; 2016 Mar; 51(3):271-80. PubMed ID: 26324191
[TBL] [Abstract][Full Text] [Related]
43. The xenobiotic-sensing nuclear receptors pregnane X receptor, constitutive androstane receptor, and orphan nuclear receptor hepatocyte nuclear factor 4alpha in the regulation of human steroid-/bile acid-sulfotransferase.
Echchgadda I; Song CS; Oh T; Ahmed M; De La Cruz IJ; Chatterjee B
Mol Endocrinol; 2007 Sep; 21(9):2099-111. PubMed ID: 17595319
[TBL] [Abstract][Full Text] [Related]
44. Hepatic copper content is normal in early primary biliary cirrhosis and primary sclerosing cholangitis.
Kowdley KV; Knox TA; Kaplan MM
Dig Dis Sci; 1994 Nov; 39(11):2416-20. PubMed ID: 7956610
[TBL] [Abstract][Full Text] [Related]
45. Overlap syndromes.
Beuers U; Rust C
Semin Liver Dis; 2005 Aug; 25(3):311-20. PubMed ID: 16143946
[TBL] [Abstract][Full Text] [Related]
46. Increased expression of TNFRSF14 and LIGHT in biliary epithelial cells of patients with primary sclerosing cholangitis.
Kanai S; Fujiwara H; Mizuno S; Kishikawa T; Nakatsuka T; Hamada T; Tanaka M; Arita J; Nakai Y; Isayama H; Kasuga M; Tateishi R; Tateishi K; Ushiku T; Hasegawa K; Koike K; Fujishiro M
Dig Liver Dis; 2024 Feb; 56(2):305-311. PubMed ID: 37722959
[TBL] [Abstract][Full Text] [Related]
47. Oncomir MicroRNA-346 Is Upregulated in Colons of Patients With Primary Sclerosing Cholangitis.
Kempinska-Podhorodecka A; Blatkiewicz M; Wunsch E; Krupa L; Gutkowski K; Milkiewicz P; Milkiewicz M
Clin Transl Gastroenterol; 2020 Jan; 11(1):e00112. PubMed ID: 31972611
[TBL] [Abstract][Full Text] [Related]
48. Prospective evaluation of PBC-specific health-related quality of life questionnaires in patients with primary sclerosing cholangitis.
Raszeja-Wyszomirska J; Wunsch E; Krawczyk M; Rigopoulou EI; Bogdanos D; Milkiewicz P
Liver Int; 2015 Jun; 35(6):1764-71. PubMed ID: 25388280
[TBL] [Abstract][Full Text] [Related]
49. Which patients with primary biliary cirrhosis or primary sclerosing cholangitis should undergo endoscopic screening for oesophageal varices detection?
Bressler B; Pinto R; El-Ashry D; Heathcote EJ
Gut; 2005 Mar; 54(3):407-10. PubMed ID: 15710991
[TBL] [Abstract][Full Text] [Related]
50. Decreased anion exchanger 2 immunoreactivity in the liver of patients with primary biliary cirrhosis.
Medina JF; Martínez-Ansó ; Vazquez JJ; Prieto J
Hepatology; 1997 Jan; 25(1):12-7. PubMed ID: 8985258
[TBL] [Abstract][Full Text] [Related]
51. Autoreactivity to hepatocellular antigens in primary biliary cirrhosis and primary sclerosing cholangitis.
Bedlow AJ; Donaldson PT; McFarlane BM; Lombard M; McFarlane IG; Williams R
J Clin Lab Immunol; 1989 Nov; 30(3):103-9. PubMed ID: 2642168
[TBL] [Abstract][Full Text] [Related]
52. Platelet function rather than plasmatic coagulation explains hypercoagulable state in cholestatic liver disease.
Pihusch R; Rank A; Göhring P; Pihusch M; Hiller E; Beuers U
J Hepatol; 2002 Nov; 37(5):548-55. PubMed ID: 12399218
[TBL] [Abstract][Full Text] [Related]
53. Thyroid dysfunction in primary biliary cirrhosis, primary sclerosing cholangitis and non-alcoholic fatty liver disease.
Silveira MG; Mendes FD; Diehl NN; Enders FT; Lindor KD
Liver Int; 2009 Aug; 29(7):1094-100. PubMed ID: 19291181
[TBL] [Abstract][Full Text] [Related]
54. Liver transplantation in PBC and PSC: indications and disease recurrence.
Carbone M; Neuberger J
Clin Res Hepatol Gastroenterol; 2011 Jun; 35(6-7):446-54. PubMed ID: 21459072
[TBL] [Abstract][Full Text] [Related]
55. Waitlist mortality and post-transplant survival in patients with cholestatic liver disease - Impact of changes in allocation policy.
Staufer K; Kivaranovic D; Rasoul-Rockenschaub S; Soliman T; Trauner M; Berlakovich G
HPB (Oxford); 2018 Oct; 20(10):916-924. PubMed ID: 29937419
[TBL] [Abstract][Full Text] [Related]
56. Protein and miRNA profile of circulating extracellular vesicles in patients with primary sclerosing cholangitis.
Povero D; Tameda M; Eguchi A; Ren W; Kim J; Myers R; Goodman ZD; Harrison SA; Sanyal AJ; Bosch J; Ohno-Machado L; Feldstein AE
Sci Rep; 2022 Feb; 12(1):3027. PubMed ID: 35194091
[TBL] [Abstract][Full Text] [Related]
57. Oxygen-derived free radical production by peripheral blood neutrophils in chronic cholestatic liver diseases.
D'Odorico A; Melis A; Baragiotta A; Martines D; Naccarato R; Floreani A
Hepatogastroenterology; 1999; 46(27):1831-5. PubMed ID: 10430355
[TBL] [Abstract][Full Text] [Related]
58. Decreased in vitro production of tumor necrosis factor in primary biliary cirrhosis patients.
Broomé U; Eriksson LS; Sundin U; Sundqvist KG
Scand J Gastroenterol; 1992; 27(2):124-8. PubMed ID: 1561525
[TBL] [Abstract][Full Text] [Related]
59. Long-term outcome of liver transplantation in patients with PSC: a comparative analysis with PBC.
Maheshwari A; Yoo HY; Thuluvath PJ
Am J Gastroenterol; 2004 Mar; 99(3):538-42. PubMed ID: 15056099
[TBL] [Abstract][Full Text] [Related]
60. Antineutrophil nuclear antibodies (ANNA) in primary biliary cirrhosis: their prevalence and antigen specificity.
Orth T; Gerken G; Meyer Zum Büschenfelde KH; Mayet WJ
Z Gastroenterol; 1997 Feb; 35(2):113-21. PubMed ID: 9066101
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
